YSB Inc. (HKG:9885)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.440
-0.240 (-5.13%)
May 12, 2026, 4:08 PM HKT
Market Cap3.19B -26.4%
Revenue (ttm)23.34B +17.1%
Net Income170.22M +409.7%
EPS0.24 +378.3%
Shares Out682.25M
PE Ratio19.12
Forward PEn/a
Dividend0.13 (2.71%)
Ex-Dividend DateMay 26, 2026
Volume2,316,400
Average Volume2,377,650
Open4.660
Previous Close4.680
Day's Range4.400 - 4.660
52-Week Range3.560 - 12.660
Beta0.61
RSI34.17
Earnings DateMar 23, 2026

About YSB Inc.

YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that include Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qu... [Read more]

Sector Healthcare
Founded 2015
Employees 6,620
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9885
Full Company Profile

Financial Performance

In 2025, YSB Inc.'s revenue was 20.97 billion, an increase of 17.13% compared to the previous year's 17.90 billion. Earnings were 152.97 million, an increase of 409.66%.

Financial numbers in CNY Financial Statements